Vaisala acquires Veriteq
Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.
Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.
Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.
"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.
2026 Nobel Prize winners announced
It's that time of year again — the first of the 2026 Nobel Prizes have been announced.
NSW Govt to launch science and innovation fund
The fund will be used to coordinate strategic investments, deliver on government priorities and...
DKSH brings Bioyond Robotics' lab automation products Down Under
DKSH will provide distribution of the Bioyond Robotics portfolio of AI-driven autonomous...
